Arlington Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Buy |
307
+3
| +1% | +$1.34K | 0.03% | 222 |
|
|
2025
Q1 | $147K | Buy |
304
+12
| +4% | +$5.82K | 0.03% | 208 |
|
|
2024
Q4 | $118K | Hold |
292
| – | – | 0.02% | 246 |
|
|
2024
Q3 | $136K | Hold |
292
| – | – | 0.03% | 217 |
|
|
2024
Q2 | $137K | Buy |
292
+233
| +395% | +$109K | 0.03% | 205 |
|
|
2024
Q1 | $24.7K | Sell |
59
-8
| -12% | -$3.34K | 0.01% | 320 |
|
|
2023
Q4 | $27.3K | Buy |
67
+33
| +97% | +$13.4K | 0.01% | 327 |
|
|
2023
Q3 | $11.8K | Buy |
+34
| New | +$11.8K | ﹤0.01% | 220 |
|